LIGAND PHARMACEUTICALS INC — Director's Dealing 2015

Aug 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2015-08-06

Reporting Person: Korenberg Matthew E (VP, Finance and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-06	Common Stock	A	6000.0	$0.0	Acquired	6000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-06	Employee Stock Option (right to buy)	$104.59	A	25000.0	Acquired	2025-08-06	Common Stock (25000)	Direct

Footnotes

F1: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 25% after one year, then 1/36th of the Optioned Shares per month thereafter.